Drugmaker Merck & Co. on Thursday posted a bigger profit in the third quarter due to slightly higher sales and a huge gain from selling a business. Full story
Insight on the $46B Schering-Plough/Merck deal, with Fred Hassan, Schering-Plough chairman/CEO.
Insight from a CEO who has been at the helm of three turnarounds and is behind the fourth largest merger this year, with Fred Hassan, Schering-Plough chairman/CEO and Howard Dean, former Vermont governor.
